This book has been designed to provide the full description of the comprehensive management of peritoneal surface malignancies which have originated from different primaries, such as breast cancer, small bowel cancers and imatinib resistant GISTosis and sarcomas and pseudomyxoma. The book provides the most up-to-date information on current approaches such as cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Given the increasing evidence that the patients who may benefit from this treatment modality avoid potential lethal course of these diseases, the book explores the application of these approaches to a number of types of malignancy.
The first chapters explore Benign Multicystic Mesothelioma and Pseudomyxoma Peritonei arising from unusual primaries. Among other explored topics are peritoneal metastases from serous papillary uterine carcinoma, sarcoma and from unusual origins.
This book is valuable for surgical oncologists who deal with the management of peritoneal surface malignancies.
Emel Canbay has a MD from Cumhuriyet University (Turkey) and PhD from University of London King's College School of Medicine and Dentistry (UK). She has had fellowships from the University of Bristol (UK); the International Centre for Genetic Engineering and Biotechnology (Italy); and Imperial Cancer Research Fund (London, UK). She has a speciality in General Surgery from Ankara, Turkey. She has been assigned from the Ministry of Health of Turkey as an attending surgeon to the Breast Units and Gastrointestinal Surgery, and Accident and Emergency Departments of Istanbul University, Istanbul Medical Faculty and Istanbul Cerrahpasa Medical Faculty for four years. She had a clinical fellowship from Peritoneal Cancer Centre in Osaka- Japan under the supervision of Dr. Yutaka Yonemura. She has completed surgical and clinical follow up over the 200 cases with peritoneal metastases in Japan. She has been working as Head of the Peritoneal Malignancy Centre and Non Profit Organization for Hyperthermic Intraperitoneal Chemotherapy (Istanbul, Turkey) since 2013.
1- Benign Multicystic Mesothelioma
2- Pseudomyxoma Peritonei arising from different origin rather than appendix and ovary
2.b. fallopian tubes
2.d. small bowel
3- Desmoplastic small round cell tumour
4- Uterine sarcoma
5- Peritoneal metastases from breast cancer
6- Peritoneal metastases from small bowel adenocarcinoma
7- Peritoneal metastases from Imatinib resistant GISTosis
8- Peritoneal metastases from serous papillary uterine carcinoma
9- Peritoneal metastases from unusal origins
9.b. Gall bladder
10- Peritoneal metastases from sarcoma
11- Peritoneal metastases from unusual miscellaneous tumours
11-a Retroperitoneal mullerian adenocarcinoma
11-b A giant mesentery malignant solitary fibrous tumour